11.89  0.13 (1.11%)		01-14 11:18
Open: 11.77 High: 11.9747 Volume: 915		Pre. Close: 11.76 Low: 11.77 Market Cap: 80(M)

Short term
Mid term
Targets	6-month :	15.93	1-year :	18.61
Resists	First :	13.64	Second :	15.93
Pivot price	11.45
Supports	First :	11.39	Second :	10.01
MAs	MA(5) :	12.07	MA(20) :	11.51
	MA(100) :	12.11	MA(250) :	12.8
MACD	MACD :	-0.1	Signal :	-0.2
%K %D	K(14,3) :	48.4	D(3) :	53.6
RSI	RSI(14): 50.1
52-week	High :	17.74	Low :	5.93

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ DRIO ] has closed below upper band by 40.0%. Bollinger Bands are 22.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	12.34 - 12.41	12.41 - 12.47
Low:	11.41 - 11.5	11.5 - 11.58
Close:	11.63 - 11.76	11.76 - 11.88

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Wed, 10 Dec 2025
DRIO - Dariohealth Corp Latest Stock News & Market Updates - Stock Titan

Tue, 02 Dec 2025
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date - PR Newswire

Mon, 24 Nov 2025
DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year - PR Newswire

Thu, 13 Nov 2025
DarioHealth Reports Third Quarter 2025 Financial and Operating Results - PR Newswire

Thu, 13 Nov 2025
DarioHealth Corp. (DRIO) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Wed, 12 Nov 2025
DarioHealth Presents New Data Demonstrating Significant Reduction in Medical Costs Among Employer Populations Using Its Digital Health Platform - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Shares Out	7 (M)
Shares Float	5 (M)
Held by Insiders	23.2 (%)
Held by Institutions	11.8 (%)
Shares Short	61 (K)
Shares Short P.Month	179 (K)

EPS	-10.87
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	11.06
Profit Margin	-171.1 %
Operating Margin	-189.5 %
Return on Assets (ttm)	-21.5 %
Return on Equity (ttm)	-63.5 %
Qtrly Rev. Growth	-32.5 %
Gross Profit (p.s.)	2.49
Sales Per Share	3.65
EBITDA (p.s.)	-5.08
Qtrly Earnings Growth	0 %
Operating Cash Flow	-27 (M)
Levered Free Cash Flow	-8 (M)

PE Ratio	-1.1
PEG Ratio	0
Price to Book value	1.07
Price to Sales	3.24
Price to Cash Flow	-3

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.